ENTITY

HLB Life Science (067630 KS)

19
Analysis
Health Care • South Korea
HLB Life Science Co., Ltd. wholesales and distributes pharmaceutical drugs. The Company through its subsidiaries provides targeted therapy, cell therapy, new drug development, medical devices production, and other related services. HLB Life Science also offers solar, geothermal, and other renewable energy engineering services.
more
Exchange Announcement • 28 Aug 2026 16:00

Decision on Acquisition of Shares or Investment Securities of Other Corporation

Exchange Announcement • 26 Aug 2026 17:09

Decision on Disposal of Shares or Investment Securities of Other Corporation

Exchange Announcement • 13 Jul 2026 20:01

Designation of overheated short-selling issues (applied by a restriction on short-selling)

Exchange Announcement • 08 Jun 2026 16:04

Results of issuance(Voluntary Disclosure)(ì œ17회차 CB)

Exchange Announcement • 15 May 2026 16:01

Suspension of Trading(중요한 ì˜ì— ì •ì§€)

x